BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21300030)

  • 1. In search of the Holy Grail: Folate-targeted nanoparticles for cancer therapy.
    Garcia-Bennett A; Nees M; Fadeel B
    Biochem Pharmacol; 2011 Apr; 81(8):976-84. PubMed ID: 21300030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles.
    Wang Y; Wang Y; Xiang J; Yao K
    Biomacromolecules; 2010 Dec; 11(12):3531-8. PubMed ID: 21086982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG-templated mesoporous silica nanoparticles exclusively target cancer cells.
    Morelli C; Maris P; Sisci D; Perrotta E; Brunelli E; Perrotta I; Panno ML; Tagarelli A; Versace C; Casula MF; Testa F; Andò S; Nagy JB; Pasqua L
    Nanoscale; 2011 Aug; 3(8):3198-207. PubMed ID: 21725561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticles.
    Zhang LK; Hou SX; Zhang JQ; Hu WJ; Wang CY
    Arch Pharm Res; 2010 Aug; 33(8):1193-8. PubMed ID: 20803122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells.
    Shmeeda H; Amitay Y; Gorin J; Tzemach D; Mak L; Ogorka J; Kumar S; Zhang JA; Gabizon A
    J Control Release; 2010 Aug; 146(1):76-83. PubMed ID: 20462513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of in vivo disulfide-reduction mediated drug release in mouse kidneys.
    Yang JJ; Kularatne SA; Chen X; Low PS; Wang E
    Mol Pharm; 2012 Feb; 9(2):310-7. PubMed ID: 22171616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.
    Hong S; Leroueil PR; Majoros IJ; Orr BG; Baker JR; Banaszak Holl MM
    Chem Biol; 2007 Jan; 14(1):107-15. PubMed ID: 17254956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
    Kim SH; Jeong JH; Chun KW; Park TG
    Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and cellular uptake of folic acid-conjugated cellulose nanocrystals for cancer targeting.
    Dong S; Cho HJ; Lee YW; Roman M
    Biomacromolecules; 2014 May; 15(5):1560-7. PubMed ID: 24716601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells.
    Ulbrich K; Michaelis M; Rothweiler F; Knobloch T; Sithisarn P; Cinatl J; Kreuter J
    Int J Pharm; 2011 Mar; 406(1-2):128-34. PubMed ID: 21185364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of nanoparticles: folate receptor.
    Kularatne SA; Low PS
    Methods Mol Biol; 2010; 624():249-65. PubMed ID: 20217601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.
    Bahrami B; Mohammadnia-Afrouzi M; Bakhshaei P; Yazdani Y; Ghalamfarsa G; Yousefi M; Sadreddini S; Jadidi-Niaragh F; Hojjat-Farsangi M
    Tumour Biol; 2015 Aug; 36(8):5727-42. PubMed ID: 26142733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging.
    Bhattacharya D; Das M; Mishra D; Banerjee I; Sahu SK; Maiti TK; Pramanik P
    Nanoscale; 2011 Apr; 3(4):1653-62. PubMed ID: 21331392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Folate receptor-mediated antitumor drugs].
    Zhao J; Cao SL; Zheng XL; Zhao B
    Yao Xue Xue Bao; 2009 Feb; 44(2):109-14. PubMed ID: 19408677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms.
    Yang SJ; Lin FH; Tsai HM; Lin CF; Chin HC; Wong JM; Shieh MJ
    Biomaterials; 2011 Mar; 32(8):2174-82. PubMed ID: 21163518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor detection using folate receptor-targeted imaging agents.
    Sega EI; Low PS
    Cancer Metastasis Rev; 2008 Dec; 27(4):655-64. PubMed ID: 18523731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.
    Zhang Y; Li J; Lang M; Tang X; Li L; Shen X
    J Colloid Interface Sci; 2011 Feb; 354(1):202-9. PubMed ID: 21094493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
    Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
    J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the chemical synthesis and drug delivery response of folate receptor-activated, polyethylene glycol-functionalized magnetite nanoparticles.
    Zhang J; Rana S; Srivastava RS; Misra RD
    Acta Biomater; 2008 Jan; 4(1):40-8. PubMed ID: 17681499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.